[go: up one dir, main page]

ES2182485T3 - Derivados de aminofenil isosazolina sustituidos utiles como agentes antimicrobianos. - Google Patents

Derivados de aminofenil isosazolina sustituidos utiles como agentes antimicrobianos.

Info

Publication number
ES2182485T3
ES2182485T3 ES99904393T ES99904393T ES2182485T3 ES 2182485 T3 ES2182485 T3 ES 2182485T3 ES 99904393 T ES99904393 T ES 99904393T ES 99904393 T ES99904393 T ES 99904393T ES 2182485 T3 ES2182485 T3 ES 2182485T3
Authority
ES
Spain
Prior art keywords
isosazoline
aminofenil
antimicrobial agents
alkyl
derivatives substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99904393T
Other languages
English (en)
Inventor
Michael R Barbachyn
Joel Morris
Donn G Wishka
Richard C Thomas
Gary J Cleek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of ES2182485T3 publication Critical patent/ES2182485T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un compuesto de fórmula I **fórmula** o sales farmacéuticamente aceptables del mismo, en la que: R1 es (a) H, (b)alquilo C1-8, que puede estar sustituido con uno o más halo, -OH, alcoxi C1-4 o aciloxi C1-4 (c) cicloalquilo C3-6, (d) alcoxi C1-8, (e) amino o (f) NH(alquilo C1-3), pudiendo estar el alquilo C1- 3 sustituido con uno o más halo; X e Y son independientemente (a) H, (b) F, o (c) CH3; W es (a) O, o (b) S; Q es (a) un resto heterocíclico de 5 miembros que tiene de uno a cuatro átomos de nitrógeno seleccionado entre las estructuras compuestas por i, ii, iii, iv, v, vi, vii, viii y ix; (b) un resto heterocíclico de 9 miembros que tiene de uno a cuatro átomos de nitrógeno seleccionados entre las estructuras compuestas por x, xi, xii, xiv, xv, xvi, xvii, y xviii; (c) un anillo heterocíclico que tiene un átomo de nitrógeno seleccionado entre las estructuras compuestas por ix, xx, xxi, xxii y xxiii;
ES99904393T 1998-02-13 1999-02-03 Derivados de aminofenil isosazolina sustituidos utiles como agentes antimicrobianos. Expired - Lifetime ES2182485T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7512698P 1998-02-13 1998-02-13

Publications (1)

Publication Number Publication Date
ES2182485T3 true ES2182485T3 (es) 2003-03-01

Family

ID=22123719

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99904393T Expired - Lifetime ES2182485T3 (es) 1998-02-13 1999-02-03 Derivados de aminofenil isosazolina sustituidos utiles como agentes antimicrobianos.

Country Status (12)

Country Link
US (1) US6069141A (es)
EP (1) EP1054874B1 (es)
JP (1) JP2002503655A (es)
AT (1) ATE222894T1 (es)
AU (1) AU757197B2 (es)
CA (1) CA2315735A1 (es)
DE (1) DE69902634T2 (es)
DK (1) DK1054874T3 (es)
ES (1) ES2182485T3 (es)
NZ (1) NZ506292A (es)
PT (1) PT1054874E (es)
WO (1) WO1999041244A1 (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999064417A2 (en) 1998-06-05 1999-12-16 Astrazeneca Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
JP2002522425A (ja) * 1998-08-07 2002-07-23 カイロン コーポレイション エストロゲンレセプターモジュレーターとしての置換イソオキサゾール
US6297242B1 (en) * 1999-08-12 2001-10-02 Ortho-Mcneil Pharmaceutical, Inc. N-substituted amidine and guanidine oxazolidinone antibacterials and methods of use thereof
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US6861433B2 (en) 2000-12-15 2005-03-01 Pharmacia & Upjohn Company Oxazolidinone photoaffinity probes
EP1349853B1 (en) 2000-12-21 2006-03-08 Pharmacia & Upjohn Company LLC Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
ES2180456B1 (es) * 2001-07-20 2004-05-01 Laboratorios S.A.L.V.A.T., S.A. Isoxazoles sustituidos y su utilizacion como antibioticos.
JP2005512975A (ja) * 2001-10-25 2005-05-12 アストラゼネカ アクチボラグ 抗菌薬として有用なイソキサゾリン誘導体
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
US6875784B2 (en) * 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
US7105547B2 (en) 2002-10-10 2006-09-12 Pharmacia And Upjohn Company Antimicrobial 1-aryl dihydropyridone compounds
ES2421139T3 (es) * 2003-07-30 2013-08-29 Rigel Pharmaceuticals, Inc. Compuestos de 2,4-pirimidindiamina para su uso en el tratamiento o la prevención de enfermedades autoinmunitarias
GB0403629D0 (en) * 2004-02-19 2004-03-24 Imp College Innovations Ltd Methods
MX2007003319A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como agentes terapeuticos.
CA2580855A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
MX2007003318A (es) 2004-09-20 2007-05-18 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como agentes terapeuticos.
CN101084212A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为硬脂酰CoA去饱和酶介导剂的用途
US8071603B2 (en) 2004-09-20 2011-12-06 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
CA2580857A1 (en) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
TW200626138A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
WO2006124897A2 (en) * 2005-05-13 2006-11-23 Lexicon Genetics Incorporated Methods and compositions for improving cognition
EP2029138A1 (en) 2005-06-03 2009-03-04 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
WO2007024789A1 (en) * 2005-08-24 2007-03-01 Lexicon Genetics Incorporated Pyrrolopyridine, pyrrolopyrimidine and pyrazolopyridine compounds, compositions comprising them, and methods of their use
CN101070308B (zh) * 2007-06-19 2011-05-04 天津药物研究院 异噁唑啉衍生物及其用途
CN101220000B (zh) * 2007-12-28 2010-12-22 天津药物研究院 酰氯和磺酰氯类衍生物及其用途
US8263630B2 (en) * 2008-02-12 2012-09-11 Bristol-Myers Squibb Company 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type I inhibitors
CN101675931B (zh) * 2008-09-19 2011-09-07 天津药物研究院 酰氯和磺酰氯类衍生物在制备抗肿瘤药物的用途
CN101781294B (zh) * 2010-03-10 2012-02-01 天津药物研究院 一类咪唑的衍生物、其制备方法和用途
EP2602248A1 (en) 2011-12-05 2013-06-12 University Of Leicester Novel pyrrole compounds
JP6356364B1 (ja) 2015-05-20 2018-07-11 アムジエン・インコーポレーテツド Ａｐｊ受容体のトリアゾールアゴニスト
WO2017192485A1 (en) 2016-05-03 2017-11-09 Amgen Inc. Heterocyclic triazole compounds as agonists of the apj receptor
MA46827A (fr) 2016-11-16 2019-09-25 Amgen Inc Composés de triazole à substitution cycloalkyle en tant qu'agonistes du récepteur apj
MA46824A (fr) 2016-11-16 2019-09-25 Amgen Inc Composés de triazole substitués par alkyle en tant qu'agonistes du récepteur apj
EP3541810B1 (en) 2016-11-16 2020-12-23 Amgen Inc. Triazole phenyl compounds as agonists of the apj receptor
US11046680B1 (en) 2016-11-16 2021-06-29 Amgen Inc. Heteroaryl-substituted triazoles as APJ receptor agonists
US10736883B2 (en) 2016-11-16 2020-08-11 Amgen Inc. Triazole furan compounds as agonists of the APJ receptor
EP3541803B1 (en) 2016-11-16 2020-12-23 Amgen Inc. Triazole pyridyl compounds as agonists of the apj receptor
CN110831599B (zh) * 2017-02-03 2023-03-28 布罗德研究所股份有限公司 用于癌症治疗的化合物、组合物和方法
US11149040B2 (en) 2017-11-03 2021-10-19 Amgen Inc. Fused triazole agonists of the APJ receptor
WO2019213006A1 (en) 2018-05-01 2019-11-07 Amgen Inc. Substituted pyrimidinones as agonists of the apj receptor
WO2021000297A1 (en) 2019-07-03 2021-01-07 Merck Sharp & Dohme Corp. Compounds and methods of use thereof as antibacterial agents
CN113372276B (zh) * 2021-05-25 2022-04-22 三峡大学 吲唑类衍生物及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL137326C (es) * 1967-08-26
US4283403A (en) * 1976-06-14 1981-08-11 Eli Lilly And Company Substituted isoxazolines for control of plant phytopathogens
IE44819B1 (en) * 1976-06-14 1982-04-07 Lilly Co Eli Isoxazoline derivatives and their use as fungicides
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
CN1046276C (zh) * 1993-11-22 1999-11-10 法玛西雅厄普约翰美国公司 取代羟基乙酰基哌嗪苯基唑烷酮酯及其用途
PT730587E (pt) * 1993-11-26 2000-05-31 Pfizer 3-aril-2-isoxazolinas como agentes anti-inflamatorios
JPH0873455A (ja) * 1994-03-15 1996-03-19 Upjohn Co:The オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
DK0788498T3 (da) * 1994-10-26 2001-11-05 Upjohn Co Phenyloxazolidinoner med antimikrobiel virkning
EP0807112B1 (en) * 1995-02-03 2001-09-05 PHARMACIA & UPJOHN COMPANY Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
ZA969622B (en) * 1995-12-13 1998-05-15 Upjohn Co Oxazolidinone antibacterial agents having a six-membered heteroaromatic ring.
US5990136A (en) * 1996-08-21 1999-11-23 Pharmacia & Upjohn Company Isoxazoline derivatives useful as antimicrobials
KR20010013192A (ko) * 1997-05-30 2001-02-26 로렌스 티. 마이젠헬더 티오카보닐 작용기를 갖는 옥사졸리디논 항균제

Also Published As

Publication number Publication date
PT1054874E (pt) 2003-01-31
JP2002503655A (ja) 2002-02-05
AU2479799A (en) 1999-08-30
WO1999041244A1 (en) 1999-08-19
US6069141A (en) 2000-05-30
DE69902634T2 (de) 2003-04-24
EP1054874B1 (en) 2002-08-28
AU757197B2 (en) 2003-02-06
DK1054874T3 (da) 2002-12-30
CA2315735A1 (en) 1999-08-19
ATE222894T1 (de) 2002-09-15
DE69902634D1 (de) 2002-10-02
NZ506292A (en) 2003-05-30
EP1054874A1 (en) 2000-11-29

Similar Documents

Publication Publication Date Title
ES2182485T3 (es) Derivados de aminofenil isosazolina sustituidos utiles como agentes antimicrobianos.
PE20021056A1 (es) Derivados de pirazol
ID29452A (id) 4-okso-1,4-dihidro-3-quinolinkarboksamida sebagai agen-agen antivirus
FI931901A0 (fi) Azolfoereningar, deras framstaellning och anvaendning
ATE230402T1 (de) Hemmer der retroviralen protease
CA2325741A1 (en) Urea derivatives having tnf- .alpha. production inhibitory effects
ECSP045224A (es) Tripéptidos inhibidores de la hepatitis c
ATE112285T1 (de) Adenosin-derivate, die eine aktivität gegen bluthochdruck haben.
ATE77083T1 (de) Benzamide protease-inhibitoren.
ID21568A (id) Penggunaan baru untuk turunan 1,3-propanadiol
ATE103177T1 (de) Verwendung von alkylphospholipiden als antivirale arzneimittel, sowie neue verbindungen.
ATE164844T1 (de) Azolverbindungen, ihre herstellung und verwendung als antimykotische mittel
EA200000787A1 (ru) Промежуточные соединения для получения ациклических нуклеозидов
YU12992A (sh) 2-amino-1,2,3,4,-tetrahidronaftaleni supstituisani u prstenu
PT1157998E (pt) Compostos heterociclicos seus intermediarios e inibidores da elastase
DE69122812D1 (de) Glutathionderivat
DK0458387T3 (da) Isochromanderivater
ATE72435T1 (de) Derivate von phenyl-, pyrrolidin-2-ylsubstituierten 5-ring heterocyclen mit antipsychotischer wirkung.
FI904728A0 (fi) Benzanilider.
FI956151A0 (fi) Iskeemisissä taudeissa käyttökelpoisia bentseenijohdannaisia
CO5180536A1 (es) Inhibidores de proteasas catepsina
UY26416A1 (es) Compuestos
DE69835966D1 (de) Medizinische anwendungen von phenylalkanolen und derivaten davon
DE69329618D1 (de) 3-oxo-1,4-benzothiazin-derivate
ATE120188T1 (de) 15-deoxyprostaglandinderivat.